Skip to content

Michelle D. Brazas

Ontario Institute for Cancer Research/Director

2025 Salary

$161,189

Total compensation $162,164, including $976 in taxable benefits.

Source: Ontario’s Public Sector Salary Disclosure — names paid $100,000 or more that year. How we build this · Report an error on this page

At a Glance
2025

Employer Rank

#32

Ontario Institute for Cancer Research

Years on List

7

2017–2025

Peak Salary

$161,189

2025

Full 2025 roster at Ontario Institute for Cancer Research →·See where $161,189 ranks →

Total Compensation History

Total compensation by yearLine chart of 7 yearly values of total compensation, from $102,525 in 2017 to $162,164 in 2025. No data for 2020. No data for 2022.$100K$120K$140K$160K$180K201720182019202320242025
Total compensation, 2017–2025. Axis starts at $100,000, the Sunshine List disclosure threshold.

Full History
2017–2025

Take-Home Pay
(After Tax) · 2025 estimate

In 2025, Michelle D. Brazas's $161,189 salary works out to roughly $110,043 after income tax, CPP and EI — an all-in deduction rate of about 31.7%. Within Ontario Institute for Cancer Research, Michelle D. Brazas's total compensation of $162,164 was the #32 of 114, against a median salary of $128,579. It is up about 13% on the $143,163 paid in 2024. This estimate leaves out pension contributions; members of OMERS, OTPP, HOOPP or OPTrust typically take home another 7–10% less.

Estimated net pay
~$110,043
Effective income-tax rate (excl. CPP/EI)
~28.3%
CPP + EI contributions
~$5,507
All-in deduction rate (incl. CPP/EI)
~31.7%
vs. 2025 Director median
−3%

Where does $161,189 rank on the Sunshine List? →

Estimate only: 2025 federal and Ontario rates, basic personal amounts, Canada employment amount and CPP/EI credits; single, employment income only, salary treated as full-year income. Ignores pension contributions (OMERS, HOOPP, OTPP, OPTrust and similar plans lower actual take-home), union dues, RRSPs and benefits.

Also at Ontario Institute for Cancer Research
2025

View all 114 employees at Ontario Institute for Cancer Research (2025) →